China Regenerative Medicine International Limited (SEHK: 8158)
Health Care · Biotechnology · HK
HK$0.26
-17.74% today · -55.3% 1Y
China Regenerative Medicine International Limited (SEHK: 8158) operates in the Biotechnology industry within the Health Care sector. The company is valued at $9.89M and employs 33 people.
Over the last twelve months the share price has lost 55.3%, trading between 0.18 and 0.66.
Tweenvest scores China Regenerative Medicine International Limited across four factors: quality 66/100, value 58/100, growth 0/100. Its strongest factor is quality.
8158 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.89M
- Revenue (TTM)
- $11.02M
- P/E
- 2.82
- EPS
- 0.09
- Dividend yield
- —
- Beta (5Y)
- -0.96
- 52-week high
- HK$0.66
- 52-week low
- HK$0.18
- Avg volume (3M)
- —
- Shares outstanding
- 304.25M
- Employees
- 33
- Next earnings
- —
About China Regenerative Medicine International Limited
China Regenerative Medicine International Limited operates as an investment holding entity, focusing on the development and distribution of a diverse portfolio of healthcare products and associated services. The company provides extensive health management solutions, covering health condition assessments, detoxification programs, fostering internal bodily balance, nourishing vital organs, and enhancing the immune system. Additionally, its beauty offerings encompass non-surgical medical aesthetics, essential dermatological care, anti-aging skin remedies, hair revitalization, skin firming treatments, localized body contouring, and intimate restoration services. Established in 1995, the organization was previously known as China Bio-Med Regeneration Technology Limited until its rebranding to China Regenerative Medicine International Limited in March 2015. Its headquarters are situated in Tsim Sha Tsui, Hong Kong.
- ISIN
- KYG2129W1380
- Founded
- 1995
- Listed since
- Jul 18, 2001
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Regentis Biomaterials Ltd.NYSEAM: RGNT | $10.47M | $1.49 | -6.88% |
| Tempest Therapeutics, Inc.NasdaqCM: TPST | $10.32M | $0.62 | -17.88% |
| Phio Pharmaceuticals Corp.NasdaqCM: PHIO | $10.12M | $0.87 | -11.00% |
| Ensysce Biosciences, Inc.NasdaqCM: ENSC | $10.08M | $0.52 | -1.65% |
| Theriva Biologics, Inc.NYSEAM: TOVX | $9.54M | $0.21 | -4.19% |
| Nextage Therapeutics LtdTASE: NXTG | $9.54M | ₪0.37 | -3.95% |
| Solvonis Therapeutics plcLSE: SVNS | $9.53M | £0.00 | -4.76% |
| CRISM Therapeutics CorporationAIM: CRTX | $9.51M | £0.09 | -2.70% |
Figures last refreshed Oct 18, 2026.